Ultrasound, antisperm antibody, and hormone profiles after testicular Trucut biopsy
Related Experiment Video
Updated: Oct 8, 2026
Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
Published on: April 9, 2019
E K Steele1, P K Ellis, S E Lewis
1School of Medicine, Department of Obstetrics and Gynecology, The Queen's University of Belfast, Grosvenor Road, Belfast BT12 6BJ, Northern Ireland, United Kingdom.
Objective:
To assess the effect of Trucut needle biopsy on the ultrasound appearances of the testis in obstructive and nonobstructive azoospermia to test serum samples for antisperm antibodies and gonadotropin and testosterone levels.
Design:
Prospective case analysis.
Setting:
IVF unit.
Patient(S):
Sixteen subjects with obstructive azoospermia had postbiopsy ultrasound scans, 18 had assessment of hormone profiles, and 20 had evaluation of antisperm antibodies.
Intervention(S):
Trucut needle testicular biopsies under local anesthetic.
Main Outcome Measure(S):
Postbiopsy testicular ultrasound, the presence of serum antisperm antibodies, and follicle stimulating and luteinizing hormone and testosterone levels.
Result(S):
There were no postbiopsy hematomas or scars, antisperm antibodies did not develop, and pituitary gonadotropins did not rise nor testosterone levels fall.
Conclusion(S):
Trucut needle testicular biopsy in men with obstructive azoospermia is not associated with defects of parenchymal structure or function.
Related Concept Videos
01:17Ultrasonography
During an ultrasonography procedure, a handheld device called a...
01:24Imaging Studies II: Ultrasonography